Catugal, Alexis John S.
HRN: 21-05-51 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/15/2022
05/22/2022
IV
70mg
Q24 For 7 Days
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes